npj Regenerative Medicine

Papers
(The H4-Index of npj Regenerative Medicine is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation178
Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application102
Scaffold-free cell-based tissue engineering therapies: advances, shortfalls and forecast84
Longevity leap: mind the healthspan gap79
Self-assembling peptide scaffolds in the clinic77
The bright side of fibroblasts: molecular signature and regenerative cues in major organs68
Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries67
Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering63
Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis54
3D in vitro M2 macrophage model to mimic modulation of tissue repair53
Macrophages in heterotopic ossification: from mechanisms to therapy53
Preclinical assessment on neuronal regeneration in the injury-related microenvironment of graphene-based scaffolds52
The evolving definition of salivary gland stem cells50
Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson’s disease48
Senolytics improve bone forming potential of bone marrow mesenchymal stem cells from aged mice48
Human gingival fibroblast secretome accelerates wound healing through anti-inflammatory and pro-angiogenic mechanisms45
The jam session between muscle stem cells and the extracellular matrix in the tissue microenvironment42
Skeletal muscle differentiation of human iPSCs meets bioengineering strategies: perspectives and challenges38
Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease38
Spiny mouse (Acomys): an emerging research organism for regenerative medicine with applications beyond the skin36
VEGF-A, PDGF-BB and HB-EGF engineered for promiscuous super affinity to the extracellular matrix improve wound healing in a model of type 1 diabetes34
Regenerative medicine meets mathematical modelling: developing symbiotic relationships34
Defining the variety of cell types in developing and adult human kidneys by single-cell RNA sequencing33
Strategies to capitalize on cell spheroid therapeutic potential for tissue repair and disease modeling33
Nerve-specific extracellular matrix hydrogel promotes functional regeneration following nerve gap injury31
The Warburg effect is necessary to promote glycosylation in the blastema during zebrafish tail regeneration31
Injectable decellularized cartilage matrix hydrogel encapsulating urine-derived stem cells for immunomodulatory and cartilage defect regeneration30
Cellularized small-caliber tissue-engineered vascular grafts: looking for the ultimate gold standard29
Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-1929
0.02590799331665